WZWenjun Zheng

Wenjun Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenjun Zheng has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular dynamics simulation of the truncated NMDA receptor in a partially restrained active-like state

    by Xing Liu, Wenjun Zheng

    The GluN1/GluN2A N-methyl-D-aspartate receptor (NMDAR) is a critical ligand-gated ion channel in the central nervous system, playing essential roles in synaptic plasticity, learning, and memory. Understanding its dynamics in the open-channel active state is paramount for deciphering its physiological functions and for developing targeted therapeutics. Despite many past efforts, the active state has not yet been fully resolved at atomic resolutions. To elucidate the molecular mechanism of the NMDAR activation, computer modeling and simulation are instrumental in providing detailed information about the dynamics and energetics of the receptor in various functional states. In this study, we started from a previously built active-like model of a truncated NMDAR (with its ligand-binding domains restrained), and explored its energetics and dynamics with extensive molecular dynamics (MD) simulation (total simulation time is 5.6 µs). Based on the MD simulation, we employed an array of analysis tools to study the fluctuations/motions at the levels of individual residues, the channel pore, and the global structure, and identified a dynamic network of polar/nonpolar interactions between residues. Furthermore, we used machine learning to identify key interactions and residues associated with channel pore opening/closing and annotated them with evolutionary conservation grades and known disease mutations in NMDAR. Taken together, our study provided rich structural/dynamic information and specific predictions for key residues/interactions which will inform future functional studies of the NMDA receptor.

  • Open Access

    Molecular dynamics simulation of the truncated NMDA receptor in the open state

    by Xing Liu, Wenjun Zheng

    The GluN1/GluN2A N-methyl-D-aspartate receptor (NMDAR) is a critical ligand-gated ion channel in the central nervous system, playing essential roles in synaptic plasticity, learning, and memory. Understanding its dynamics in the open/active state is paramount for deciphering its physiological functions and for developing targeted therapeutics. Despite many past efforts, the active/open state has not yet been fully resolved at atomic resolutions. To elucidate the molecular mechanism of the NMDAR activation, computer modeling and simulation are instrumental in providing detailed information about the dynamics and energetics of the receptor in various functional states. In this study, we started from a previously built open-state model of a truncated NMDAR, and then explored its energetics and dynamics with extensive molecular dynamics (MD) simulation (total simulation time is 5.6 µs). Based on the MD simulation, we employed an array of analysis tools to study the fluctuations/motions at the levels of individual residues, the channel pore, and the global structure, and identified a dynamic network of polar/nonpolar interactions between residues. Furthermore, we used machine learning to identify key interactions and residues relevant to channel opening/closing and validated them with evolutionary conservation grades and annotations of disease mutations in NMDAR. Taken together, our modeling and simulation provided rich structural and dynamic information which will guide functional studies of the activation of this key receptor.

  • Allosteric inhibition of NMDA receptors by low dose ketamine

    by Jamie A. Abbott, Han Wen, Beiying Liu, Sheila S. Gupta, Gary J. Iacobucci, Wenjun Zheng, Gabriela K. Popescu

    Ketamine, a general anesthetic, has rapid and sustained antidepressant effects when administered at lower doses. Anesthetic levels of ketamine reduce excitatory transmission by binding deep into the pore of NMDA receptors where it blocks current influx. In contrast, the molecular targets responsible for antidepressant levels of ketamine remain controversial. We used electrophysiology, structure-based mutagenesis, and molecular and kinetic modeling to investigate the effects of ketamine on NMDA receptors across an extended range of concentrations. We report functional and structural evidence that, at nanomolar concentrations, ketamine interacts with membrane-accessible hydrophobic sites on NMDA receptors, which are distinct from the established pore-blocking site. These interactions stabilize receptors in pre-open states and produce an incomplete, voltage- and pH-dependent reduction in receptor gating. Notably, this allosteric inhibitory mechanism spares brief synaptic-like receptor activations and preferentially reduces currents from receptors activated tonically by ambient levels of neurotransmitters. We propose that the hydrophobic sites we describe here account for clinical effects of ketamine not shared by other NMDA receptor open-channel blockers such as memantine and represent promising targets for developing safe and effective neuroactive therapeutics.


  • Open Access

    Predicting hotspots for disease-causing single nucleotide variants using sequences-based coevolution, network analysis, and machine learning

    by Wenjun Zheng

    To enable personalized medicine, it is important yet highly challenging to accurately predict disease-causing mutations in target proteins at high throughput. Previous computational methods have been developed using evolutionary information in combination with various biochemical and structural features of protein residues to discriminate neutral vs. deleterious mutations. However, the power of these methods is often limited because they either assume known protein structures or treat residues independently without fully considering their interactions. To address the above limitations, we build upon recent progress in machine learning, network analysis, and protein language models, and develop a sequences-based variant site prediction workflow based on the protein residue contact networks: 1. We employ and integrate various methods of building protein residue networks using state-of-the-art coevolution analysis tools (RaptorX, DeepMetaPSICOV, and SPOT-Contact) powered by deep learning. 2. We use machine learning algorithms (Random Forest, Gradient Boosting, and Extreme Gradient Boosting) to optimally combine 20 network centrality scores to jointly predict key residues as hot spots for disease mutations. 3. Using a dataset of 107 proteins rich in disease mutations, we rigorously evaluate the network scores individually and collectively (via machine learning). This work supports a promising strategy of combining an ensemble of network scores based on different coevolution analysis methods (and optionally predictive scores from other methods) via machine learning to predict hotspot sites of disease mutations, which will inform downstream applications of disease diagnosis and targeted drug design.


  • Modeling and Simulation of the NMDA Receptor at Coarse-Grained and Atomistic Levels

    by Wenjun Zheng, Xing Liu

    N-Methyl-D-aspartate (NMDA) receptors are glutamate-gated excitatory channels that play essential roles in brain functions. While high-resolution structures were solved for an allosterically inhibited form of functional NMDA receptor, other key functional states (particularly the active open-channel state) have not yet been resolved at atomic resolutions. To decrypt the molecular mechanism of the NMDA receptor activation, structural modeling and simulation are instrumental in providing detailed information about the dynamics and energetics of the receptor in various functional states. In this chapter, we describe coarse-grained modeling of the NMDA receptor using an elastic network model and related modeling/analysis tools (e.g., normal mode analysis, flexibility and hotspot analysis, cryo-EM flexible fitting, and transition pathway modeling) based on available structures. Additionally, we show how to build an atomistic model of the active-state receptor with targeted molecular dynamics (MD) simulation and explore its energetics and dynamics with conventional MD simulation. Taken together, these modeling and simulation can offer rich structural and dynamic information which will guide experimental studies of the activation of this key receptor.

  • Open Access

    Pharmacokinetics and pharmacodynamics of mibavademab (a leptin receptor agonist): Results from a first‐in‐human phase I study

    by Andrew Gewitz, Jeanne Mendell, Yuhuan Wang, Charles Harris, Benjamin A. Olenchock, Simona Podgrabinska, Wenjun Zheng, An Zhao, Hao Pan, Frédéric Vanhoutte, et al.

    Mibavademab (previously known as REGN4461), a fully human monoclonal antibody, is being investigated for the treatment of conditions associated with leptin deficiency. Here, we report pharmacokinetics (PKs), pharmacodynamics, and immunogenicity from a phase I study in healthy participants (NCT03530514). In part A, lean or overweight healthy participants were randomized to single‐ascending‐dose cohorts of 0.3, 1.0, 3.0, 10, and 30 mg/kg intravenous (i.v.), or 300 and 600 mg subcutaneous doses of mibavademab or placebo. In part B, overweight or obese participants were randomized to receive multiple doses of mibavademab (15 mg/kg i.v. loading dose and 10 mg/kg i.v. at weeks 3, 6, and 9) or placebo, stratified by body mass index and baseline leptin levels: low leptin (<5 ng/mL) or relatively low leptin (5–8 ng/mL in men and 5–24 ng/mL in women). Fifty‐six and 55 participants completed the single‐ascending‐dose and multiple‐dose parts, respectively. In the single‐ascending‐dose cohorts, mibavademab PKs were nonlinear with target‐mediated elimination, greater than dose‐proportional increases in exposure, and there were no dose‐dependent differences in total soluble leptin receptor (sLEPR) levels in serum over time. Following multiple‐dose administration of mibavademab in participants with leptin <8 ng/mL, lower mean mibavademab concentrations, higher mean total sLEPR concentrations, and larger mean decreases in body weight than in the relatively low leptin cohorts were observed. Baseline leptin was correlated with mibavademab PKs and pharmacodynamics. No treatment‐emergent anti‐mibavademab antibodies were observed in any mibavademab‐treated participant. Results from this study collectively inform further development of mibavademab to treat conditions associated with leptin deficiency.


  • Open Access

    Predicting hotspots for disease-causing single nucleotide variants using sequences-based coevolution, network analysis, and machine learning

    by Wenjun Zheng

    To enable personalized genetics and medicine, it is important yet highly challenging to accurately predict disease-causing mutations from the sequences alone at high throughput. To meet this challenge, we build upon recent progress in machine learning, network analysis, and protein language models, and develop a sequences-based variant site prediction workflow based on the protein residue contact networks: 1. We employ and integrate various methods of building protein residue networks using state-of-the-art coevolution analysis tools (e.g., RaptorX, DeepMetaPSICOV, and SPOT-Contact) powered by deep learning. 2. We use machine learning algorithms (e.g., Random Forest, Gradient Boosting, and Extreme Gradient Boosting) to optimally combine 13 network centrality scores (calculated by NetworkX) with 7 other network scores calculated from the contact probability matrices to jointly predict key residues as hot spots for disease mutations. 3. Using a dataset of 107 proteins rich in disease mutations, we rigorously evaluate the network scores individually and collectively in comparison with alternative structures-based network scores (using predicted structures by AlphaFold). By optimally combing three coevolution analysis methods and the resulting network scores by machine learning, we are able to discriminate deleterious and neutral mutation sites accurately (AUC of ROC ~ 0.84). Furthermore, by combining our method with a state-of-the-art predictor of the functional effects of sequence variations based on large protein language models, we have significantly improved the prediction of disease variant sites (AUC ~ 0.89). This work supports a promising strategy of combining an ensemble of network scores based on different coevolution analysis methods via machine learning to predict candidate sites of disease mutations, which will inform downstream applications of disease diagnosis and targeted drug design.

  • Predicting allosteric sites using fast conformational sampling as guided by coarse-grained normal modes

    by Wenjun Zheng

    To computationally identify cryptic binding sites for allosteric modulators, we have developed a fast and simple conformational sampling scheme guided by coarse-grained normal modes solved from the elastic network models followed by atomistic backbone and sidechain reconstruction. Despite the complexity of conformational changes associated with ligand binding, we previously showed that simply sampling along each of the lowest 30 modes can adequately restructure cryptic sites so they are detectable by pocket finding programs like Concavity. Here, we applied this method to study four classical examples of allosteric regulation (GluR2 receptor, GroEL chaperonin, GPCR, and myosin). Our method along with alternative methods has been utilized to locate known allosteric sites and predict new promising allosteric sites. Compared with other sampling methods based on extensive molecular dynamics simulation, our method is both faster (1–2 h for an average-size protein of ∼400 residues) and more flexible (it can be easily integrated with any structure-based pocket finding methods), so it is suitable for high-throughput screening of large datasets of protein structures at the genome scale.


  • Complex functional phenotypes of NMDA receptor disease variants

    by Gary J. Iacobucci, Beiying Liu, Han Wen, Brittany Sincox, Wenjun Zheng, Gabriela K. Popescu

    NMDA receptors have essential roles in the physiology of central excitatory synapses and their dysfunction causes severe neuropsychiatric symptoms. Recently, a series of genetic variants have been identified in patients, however, functional information about these variants is sparse and their role in pathogenesis insufficiently known. Here we investigate the mechanism by which two GluN2A variants may be pathogenic. We use molecular dynamics simulation and single-molecule electrophysiology to examine the contribution of GluN2A subunit-residues, P552 and F652, and their pathogenic substitutions, P552R and F652V, affect receptor functions. We found that P552 and F652 interact during the receptors’ normal activity cycle; the interaction stabilizes receptors in open conformations and is required for a normal electrical response. Engineering shorter side-chains at these positions (P552A and/or F652V) caused a loss of interaction energy and produced receptors with severe gating, conductance, and permeability deficits. In contrast, the P552R side chain resulted in stronger interaction and produced a distinct, yet still drastically abnormal electrical response. These results identify the dynamic contact between P552 and F652 as a critical step in the NMDA receptor activation, and show that both increased and reduced communication through this interaction cause dysfunction. Results show that subtle differences in NMDA receptor primary structure can generate complex phenotypic alterations whose binary classification is too simplistic to serve as a therapeutic guide.


  • Open Access

    Complex functional phenotypes of NMDA receptor disease variants

    by Gary J Iacobucci, Beiying Liu, Han Wen, Brittany Sincox, Wenjun Zheng, Gabriela K. Popescu

    NMDA receptors have essential roles in the physiology of central excitatory synapses and their dysfunction causes severe neuropsychiatric symptoms. Recently, a series of genetic variants have been identified in patients, however, functional information about these variants is sparse and their role in pathogenesis insufficiently known. Here we investigate the mechanism by which two GluN2A variants may be pathogenic. We use molecular dynamics simulation and single-molecule electrophysiology to examine the contribution of GluN2A subunit-residues, P552 and F652, and their pathogenic substitutions, P552R and F652V, affect receptor functions. We found that P552 and F652 interact during the receptors’ normal activity cycle; the interaction stabilizes receptors in open conformations and is required for a normal electrical response. Engineering shorter side-chains at these positions (P552A and/or F652V) caused a loss of interaction energy and produced receptors with severe gating, conductance, and permeability deficits. In contrast, the P552R sidechain resulted in stronger interaction and produced a distinct, yet still drastically abnormal electrical response. These results identify the dynamic contact between P552 and F652 as a critical step in the NMDA receptor activation, and show that both increased and reduced communication through this interaction cause dysfunction. Results show that subtle differences in NMDA receptor primary structure can generate complex phenotypic alterations whose binary classification is too simplistic to serve as a therapeutic guide. Main findings Two NMDA receptor residues whose substitution results in encephalopathies, were found to form new interactions during activation, and the energy provided by this interaction is required for normal receptor gating. Experimental substitutions of these residues that change the strength of their interaction reduce the receptor open probability, unitary conductance, and calcium permeability. Receptors with variations at these positions identified in patients display a broad range of both gain- and loss-of-function changes depending on the stimulation protocol.